Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3439908 | American Journal of Obstetrics and Gynecology | 2008 | 10 Pages |
Abstract
Nuclear factor kappa-B activation/p65 and progesterone receptor isoform B immunoreactivity in ovarian endometrioma jointly constitutes a good biomarker for recurrence. The close relationship between nuclear factor kappa-B activation/p65 subunit and progesterone receptor isoform B immunoreactivity strongly suggests their roles involved in recurrence and may thus be excellent therapeutic targets to prevent recurrence. Our finding supports the notion that there are identifiable molecular genetic differences intrinsic to ovarian endometriomas that confer recurrence risk differential.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Fanghua Shen, Yuedong PhD, Yuan MD, PhD, Lei MD, Xishi MD, PhD, Sun-Wei PhD,